GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » TalkMed Group Ltd (SGX:5G3) » Definitions » Gross Profit

TalkMed Group (SGX:5G3) Gross Profit : S$78.18 Mil (TTM As of Dec. 2024)


View and export this data going back to 2014. Start your Free Trial

What is TalkMed Group Gross Profit?

TalkMed Group's gross profit for the six months ended in Dec. 2024 was S$45.06 Mil. TalkMed Group's gross profit for the trailing twelve months (TTM) ended in Dec. 2024 was S$78.18 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. TalkMed Group's gross profit for the six months ended in Dec. 2024 was S$45.06 Mil. TalkMed Group's Revenue for the six months ended in Dec. 2024 was S$45.06 Mil. Therefore, TalkMed Group's Gross Margin % for the quarter that ended in Dec. 2024 was N/A%.

TalkMed Group had a gross margin of N/A% for the quarter that ended in Dec. 2024 => No sustainable competitive advantage


TalkMed Group Gross Profit Historical Data

The historical data trend for TalkMed Group's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TalkMed Group Gross Profit Chart

TalkMed Group Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 62.14 60.75 76.60 83.79 78.18

TalkMed Group Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 44.13 37.80 46.00 33.12 45.06

Competitive Comparison of TalkMed Group's Gross Profit

For the Medical Care Facilities subindustry, TalkMed Group's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TalkMed Group's Gross Profit Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, TalkMed Group's Gross Profit distribution charts can be found below:

* The bar in red indicates where TalkMed Group's Gross Profit falls into.


;
;

TalkMed Group Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

TalkMed Group's Gross Profit for the fiscal year that ended in Dec. 2024 is calculated as

Gross Profit (A: Dec. 2024 )=Revenue - Cost of Goods Sold
=78.181 - 0
=78.18

TalkMed Group's Gross Profit for the quarter that ended in Dec. 2024 is calculated as

Gross Profit (Q: Dec. 2024 )=Revenue - Cost of Goods Sold
=45.062 - 0
=45.06

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was S$78.18 Mil.

Gross Profit is the numerator in the calculation of Gross Margin. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

TalkMed Group's Gross Margin % for the quarter that ended in Dec. 2024 is calculated as

Gross Margin % (Q: Dec. 2024 )=Gross Profit (Q: Dec. 2024 ) / Revenue (Q: Dec. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=45.06 / 45.062
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


TalkMed Group  (SGX:5G3) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

TalkMed Group had a gross margin of N/A% for the quarter that ended in Dec. 2024 => No sustainable competitive advantage


TalkMed Group Gross Profit Related Terms

Thank you for viewing the detailed overview of TalkMed Group's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


TalkMed Group Business Description

Traded in Other Exchanges
N/A
Address
3 Mount Elizabeth, Mount Elizabeth Hospital Level 2, Singapore, SGP, 228510
TalkMed Group Ltd operates as an investment holding company. It is a provider of medical oncology, stem cell transplants and palliative care services, serving patients in Singapore and the region. Outside Singapore, the Group operates in Vietnam, Hong Kong and the People's Republic of China. The activities of the company are the provision of medical oncology services and palliative care healthcare services in Singapore. It is organized into two reportable operating segments, Oncology Services and Cellular and gene therapy-related products and services. The company has operational footprints across Singapore, China and Hong Kong, Australia, Vietnam and others of which Singapore contributes the vast majority of total revenue. It generates maximum revenue from the Oncology services segment.

TalkMed Group Headlines

No Headlines